<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Prévot, Anne</dc:creator>
  <dc:creator>Julita, Monique</dc:creator>
  <dc:creator>Tung, David K.</dc:creator>
  <dc:creator>Mosig, Dolores</dc:creator>
  <dc:date>2009-01-24</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Acute normocapnic hypoxemia can cause functional renal insufficiency by increasing  renal vascular resistance (RVR), leading to renal hypoperfusion and decreased  glomerular filtration rate (GFR). Insulin-like growth factor 1 (IGF-1) activity is low in  fetuses and newborns and further decreases during hypoxia. IGF-1 administration to  humans and adult animals induces pre- and postglomerular vasodilation, thereby  increasing GFR and renal blood flow (RBF). A potential protective effect of IGF-1 on  renal function was evaluated in newborn rabbits with hypoxemia-induced renal  insufficiency. Renal function and hemodynamic parameters were assessed in 17  anesthetized and mechanically ventilated newborn rabbits. After hypoxemia  stabilization, saline solution (time control) or IGF-1 (1 mg/kg) was given as an  intravenous (i.v.) bolus, and renal function was determined for six 30-min periods.  Normocapnic hypoxemia significantly increased RVR (+16%), leading to decreased  GFR (−14%), RBF (−19%) and diuresis (−12%), with an increased filtration fraction  (FF). Saline solution resulted in a worsening of parameters affected by hypoxemia.  Contrarily, although mean blood pressure decreased slightly but significantly, IGF-1  prevented a further increase in RVR, with subsequent improvement of GFR, RBF and  diuresis. FF indicated relative postglomerular vasodilation. Although hypoxemia- induced acute renal failure was not completely prevented, IGF-1 elicited efferent  vasodilation, thereby precluding a further decline in renal function.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/301221</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/301221/files/467_2008_Article_1098.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/s00467-008-1098-1</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Pediatric Nephrology. - 2009, vol. 24, no. 5, p. 973-981</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Hypoxemia</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Insulin-like growth factor-1</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Kidney</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Newborn rabbit</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Survival</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns6="xml" ns6:lang="en">Beneficial effect of insulin-like growth factor-1 on hypoxemic renal dysfunction in the newborn rabbit</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
